Clinical Trials Insight: 700028547

Trial Profile

Clinical Trials Insight: 700028547

Phase of Trial: Phase I

Latest Information Update: 13 Feb 2008

At a glance

  • Drugs Elpetrigine (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Sponsors Jazz Pharmaceuticals Inc
  • Most Recent Events

    • 13 Feb 2008 Status changed from in progress to completed according to Jazz Pharmaceuticals media release.
    • 16 Nov 2007 New trial record.
    • 06 Nov 2007 This trial is expected to be completed in the fourth quarter in 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top